Hemodialysis. Chronic kidney disease, stage 5
Conditions
Interventions
Intervention 1: In the intervention group, nettle tablet. Intervention 2: There is no intervention in the control group.
Treatment - Drugs
In the intervention group, nettle tablet
Sponsors
Vice Chancellor for Research Mazandaran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: The criteria for entering the study include consenting to participate in research, dialysis treatment at least two times a week, at least 3 months, and 18 years of age and older. Exit criteria also include known psychiatric disorders, diabetes mellitus, urticaria ; Myomia; menorrhagia; history of gastrointestinal bleeding; mental disorders; heart failure; coronary artery stenosis or myocardial infarction; systolic blood pressure less than 90 mm Hg and substance abuse
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of Life. Timepoint: end of every month duration 3 month. Method of measurement: pitsburg questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Patients Wellbeing. Timepoint: Every three months. Method of measurement: Questionaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactKhadije Alizade
Mazandaran University of Medical Sciences - Faculty of Nursing and Midwifery Nasseibeh
Outcome results
None listed